Lifeward Acquires Skelable Technology Assets for $480,000
Lifeward announced it has entered into a definitive agreement to acquire certain technology assets and related know-how, including functional prototypes from Skelable, the developer of a robotic upper body orthotic device with AI capabilities, for total consideration of $480,000 in Lifeward equity, payable in installments upon the achievement of specified milestones, and a nominal cash payment at closing. As part of the acquisition, the key engineering team will join Lifeward, bringing more than 60 years of combined experience across electrical, software, mechanical and industrial design. The integration of the core engineering team will ensure continuity of knowledge and a disciplined transfer of technology, intellectual property and design intent into Lifeward's development framework. "This upper-limb orthotic technology is a natural extension of our ReWalk platform and accelerates Lifeward's evolution into a fully integrated, whole-body neuro-rehabilitation company," said Mark Grant, President and CEO of Lifeward. "The device is designed not only to support immediate functional movement, but to rehabilitate and restore independence over time. This acquisition expands our addressable market, enhances commercial efficiency through shared channels, and strengthens our position across payers and prescribers. We are also adding exceptional engineering talent that will significantly expand our internal R&D capabilities and accelerate innovation across our platform."
